Comparison results
| Results: Differences General | ✘Antithrombin II deficiency | ✘Campomelic dysplasia | ||||||||||
| Related research | Analogs | Analogs | ||||||||||
| ||||||||||||
| Distinctive symptoms | ||||||||||||
| Register, to see more distinctive signs of diseases and studies | 25% | — | ||||||||||
| Register, to see more distinctive signs of diseases and studies | — | 100% | ||||||||||
| thrombosis | 13% | — | ||||||||||
| dystrophy | — | 51% | ||||||||||
| pregnancy | 12% | — | ||||||||||
| anomalies of kidney development | — | 42% | ||||||||||
| ileofemoral thrombosis | 12% | — | ||||||||||
| bone deformation | — | 42% | ||||||||||
| nose thrombophilia | 11% | — | ||||||||||
| cardiorenal syndrome in children | — | 41% | ||||||||||
| thrombin time is lowered | 11% | — | ||||||||||
| deformities of the limbs | — | 39% | ||||||||||
| antithrombin is lowered | 10% | — | ||||||||||
| childhood diseases | — | 35% | ||||||||||
| actv increased | 10% | — | ||||||||||
| congestive kidney | — | 34% | ||||||||||
| impaired arterial function | 9% | — | ||||||||||
| microcephaly | — | 33% | ||||||||||
| thrombophlebitis | 8% | — | ||||||||||
| spinal abnormalities | — | 32% | ||||||||||
| decrease sodium | 8% | — | ||||||||||
| harelip | — | 30% | ||||||||||
| deep vein thrombosis | 8% | — | ||||||||||
| death of the child | — | 29% | ||||||||||
| 2 trimester of pregnancy | 8% | — | ||||||||||
| chest deformity | — | 29% | ||||||||||
| habitual miscarriage | 8% | — | ||||||||||
| medical abortion | — | 28% | ||||||||||
| thrombosis of the lower extremities | 8% | — | ||||||||||
| variable symptoms | — | 26% | ||||||||||
| 3 trimester of pregnancy | 8% | — | ||||||||||
| history of surgery | — | 26% | ||||||||||
| miscarriage | 7% | — | ||||||||||
| abortions | — | 26% | ||||||||||
| 2 pregnancy | 7% | — | ||||||||||
| vacuum | — | 26% | ||||||||||
| phlebitis | 7% | — | ||||||||||
| protein reduced | — | 25% | ||||||||||
| drug poisoning | 7% | — | ||||||||||
| protein c deficiency | — | 24% | ||||||||||
| 3 pregnancy | 7% | — | ||||||||||
| 2 children | — | 24% | ||||||||||
| criticality | 6% | — | ||||||||||
| antenatal death | 8% | 30% | ||||||||||
| calcium | 6% | — | ||||||||||
| antenatal fetal death | 8% | 30% | ||||||||||
| bleeding | 6% | — | ||||||||||
| kidney diseases | — | 22% | ||||||||||
| intoxication | 6% | — | ||||||||||
| surgical infections | — | 22% | ||||||||||
| inflammation | 5% | — | ||||||||||
| death of a loved | 7% | 27% | ||||||||||
| death of relatives | 7% | 27% | ||||||||||
| impaired venous function | 6% | 22% | ||||||||||
| increased | 5% | 18% | ||||||||||
| lowered | 8% | 19% | ||||||||||
Instructions
Video 
|
